Fund will be classified as Article 9 under SFDR
Fund will consist of 30-50 holdings
Main focus on pharma and biotech
Changing perceptions vital to real ESG progress
Changing perceptions vital to real ESG progress
Creating "transformational change" with Positive Future fund
Value and regional-oriented strategies in pipeline
Fund selector insights into sustainable investing
Role to cover real estate and agriculture